NAMPT and colorectal carcinoma: To identify novel pathways related to Nampt and NAD+ metabolism, we conducted RNA sequencing of the CRC cell line MC38 treated with PBS, FK866 (a Nampt inhibitor), or FK866 + NMN (the downstream intermediate of Nampt) (Figure 2D).